Don't forget, remdesivir had no efficay for preventing death. So all remdesivir did was get people WHO WOULD HAVE RECOVERED ANYWAY ON THEIR OWN oit of the hospital 4 days sooner...and that was in the S/C group. This is a REALLY low bar.

It will be hypocracy beyone belief if leronlimab shows people leaving hospitals sooner amongst the m2m group and the EFF-DA requests ph3.